Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
52.83
+0.33 (0.63%)
Sep 11, 2025, 11:07 AM - Market open
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $3.59 billion as of September 11, 2025. Its market cap has decreased by -51.72% in one year.
Market Cap
3.59B
Enterprise Value
3.49B
1-Year Change
-51.72%
Ranking
Category
Stock Price
$52.83
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $3.59B, an increase of 1,907.90%. That is a compound annual growth rate of 34.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 3.57B | -42.61% |
| Dec 31, 2024 | 6.22B | 46.48% |
| Dec 29, 2023 | 4.25B | 21.06% |
| Dec 30, 2022 | 3.51B | 79.37% |
| Dec 31, 2021 | 1.96B | 116.78% |
| Dec 31, 2020 | 902.10M | 12.06% |
| Dec 31, 2019 | 805.00M | 33.72% |
| Dec 31, 2018 | 602.00M | -21.51% |
| Dec 29, 2017 | 767.00M | 149.67% |
| Dec 30, 2016 | 307.20M | 188.72% |
| Dec 31, 2015 | 106.40M | -40.53% |
| Jun 25, 2015 | 178.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |